Literature DB >> 24081510

Molecular alterations of bone quality in sequesters of bisphosphonates-related osteonecrosis of the jaws.

C Olejnik1, G Falgayrac, A During, M H Vieillard, J M Maes, B Cortet, G Penel.   

Abstract

UNLABELLED: Compared to healthy bone, the intrinsic bone materials properties in the pre-existing lamellar bone are altered in jaw bone sequesters of bisphosphonates (BP)-related osteonecrosis.
INTRODUCTION: The aim of this study was to evaluate the human jaw bone quality, especially intrinsic bone material properties among sequesters of osteonecrosis of the jaw (ONJ) induced by BP.
METHODS: Bone sequesters were obtained from 24 patients suffering from ONJ following a BP treatment. Within BP-exposed bone samples, benign-BP and malignant-BP groups were distinguished in relation to the underlying disease: osteoporosis and bone metastases or multiple myeloma, respectively. Healthy cadaveric cortical jaw bone samples were used as controls. The physicochemical parameters of bone samples - mineral/organic ratio, relative proteoglycan content, crystallinity, monohydrogen phosphate content, and type-B carbonate substitution - were evaluated by Raman microspectroscopy. Representative Raman spectral features of bones control and BP-exposed bone sequesters were identified with the Partial-Least-Square Discriminant Analysis (PLS-DA).
RESULTS: BP-exposed bone sequesters are characterized by a significant increase of mineral to organic ratio (+12 %) and a significant decrease of relative proteoglycan content (-35 %), thus regulating initial collagen matrix mineral deposition. Structural changes on mineral components are revealed by a significant decrease of both crystallinity (-2 %) and mineral maturation (-41 %) in the BP-exposed bone sequesters compared to healthy bones. These modifications were also observed distinctly in both benign-BP and malignant-BP groups. In addition, a shift of the phosphate ν1 band was highlighted by PLS-DA between bones control and BP-exposed bone sequesters, revealing a disruption of the apatitic phosphate environment in the jaw bone sequesters.
CONCLUSIONS: The present data show that jaw bone quality can be altered with an overmineralization and ultrastructural modifications of apatitic mineral in bone sequesters of BP-related ONJ.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081510     DOI: 10.1007/s00198-013-2514-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  45 in total

1.  Osteoradionecrosis (ORN) of the mandible: a laser Raman spectroscopic study.

Authors:  R Jyothi Lakshmi; Mohan Alexander; Jacob Kurien; K K Mahato; V B Kartha
Journal:  Appl Spectrosc       Date:  2003-09       Impact factor: 2.388

2.  New method for Raman investigation of the orientation of collagen fibrils and crystallites in the Haversian system of bone.

Authors:  Guillaume Falgayrac; Sébastien Facq; Gérard Leroy; Bernard Cortet; Guillaume Penel
Journal:  Appl Spectrosc       Date:  2010-07       Impact factor: 2.388

3.  The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade.

Authors:  Janardhan S Yerramshetty; Cora Lind; Ozan Akkus
Journal:  Bone       Date:  2006-07-21       Impact factor: 4.398

Review 4.  Osteonecrosis of the jaw: who gets it, and why?

Authors:  Ian R Reid
Journal:  Bone       Date:  2008-10-07       Impact factor: 4.398

5.  Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.

Authors:  Chih-Tai Leu; Eva Luegmayr; Leonard P Freedman; Gideon A Rodan; Alfred A Reszka
Journal:  Bone       Date:  2005-09-26       Impact factor: 4.398

6.  Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate.

Authors:  D Wen; L Qing; G Harrison; E Golub; S O Akintoye
Journal:  Oral Dis       Date:  2010-12-02       Impact factor: 3.511

7.  Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.

Authors:  Erich Durchschlag; Eleftherios P Paschalis; Ruth Zoehrer; Paul Roschger; Peter Fratzl; Robert Recker; Roger Phipps; Klaus Klaushofer
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

8.  Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces.

Authors:  Birgit Hofstetter; Sonja Gamsjaeger; Roger J Phipps; Robert R Recker; Frank H Ebetino; Klaus Klaushofer; Eleftherios P Paschalis
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

9.  Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women.

Authors:  G Y Boivin; P M Chavassieux; A C Santora; J Yates; P J Meunier
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

10.  Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.

Authors:  M Saito; S Mori; T Mashiba; S Komatsubara; K Marumo
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 5.071

View more
  3 in total

Review 1.  Contributions of Raman spectroscopy to the understanding of bone strength.

Authors:  Gurjit S Mandair; Michael D Morris
Journal:  Bonekey Rep       Date:  2015-01-07

2.  Raman Spectroscopy detects changes in Bone Mineral Quality and Collagen Cross-linkage in Staphylococcus Infected Human Bone.

Authors:  Mohamed Khalid; Tanujjal Bora; Ahmed Al Ghaithi; Sharanjit Thukral; Joydeep Dutta
Journal:  Sci Rep       Date:  2018-06-20       Impact factor: 4.379

Review 3.  Raman Spectroscopy: Guiding Light for the Extracellular Matrix.

Authors:  Mads S Bergholt; Andrea Serio; Michael B Albro
Journal:  Front Bioeng Biotechnol       Date:  2019-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.